south africa: south africa conducts trials for shorter tb treatment

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update SOUTH AFRICA: South Africa Conducts Trials for Shorter TB Treatment
April 4, 2012

Agence France Presse (03.30.12) - Wednesday, April 04, 2012 Medical trials that aim to shorten the duration of TB treatment are underway in South Africa, according to researchers. "Fighting tuberculosis is going to require new strategies," said Gavin Churchyard, CEO of the independent research body the Aurum Institute. "The ongoing trial aimed at reducing the treatment period from six to four months is one of the new strategies of fighting the disease." The TB Research Center, which is based in a public hospital in the Tembisa township east of Johannesburg, is the trial site. Tembisa has a high TB infection rate. Many TB patients fail to complete treatment due to difficulty adhering to the months-long regimen and tolerating the medicines' side effects. "The long period of treatment has been identified as one of the reasons for poor adherence, resulting in drug-resistant TB strains, which are more expensive to treat," said Christopher Viehbacher, CEO of the French pharmaceutical firm Sanofi. Aurum has partnered with Sanofi to increase TB research capacity. "No organization can work alone to make a meaningful contribution towards eliminating the disease," said Viehbacher.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 SWITZERLAND: Swiss TB Rate Below European Average SOUTH CAROLINA: DHEC Orders North Charleston Clinic to Halt Invasive Procedures CANADA: New Facility Unveiled for Homeless With Hepatitis C FLORIDA: Gospel of Health: Block Party Promotes HIV and AIDS Awareness CALIFORNIA: 2Cents Theatre Group Announces Plans to Benefit HIV/AIDS Organizations with RENT UNITED STATES: HCV Prevalence Higher Among Asian-Americans WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM MICHIGAN: Michigan Department of Community Health Encourages Testing for America's Silent Epidemic: Viral Hepatitis Fight Breast Cancer and More at Walk The World, A First of Its Kind Walkathon at The Walt Disney World Resort in Florida When it comes to deadly viruses, what's in a name? SWITZERLAND: Swiss TB Rate Below European Average SOUTH CAROLINA: DHEC Orders North Charleston Clinic to Halt Invasive Procedures Study Finds Vitamin C Can Kill Drug-Resistant TB UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall CALIFORNIA: $50,000 Prisoner Prescription: Inmates Get Expensive Hepatitis C Treatment South Africa: Mandela name pulled into politics ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment Uganda: HIV Vaccine Trials to Start in July TB, HIV and malaria vaccine research gets major boost People with HIV pay more for life insurance – if they can get it (South Africa)
Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles. Information in this article was accurate in April 4, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.